TriNetX Announces the Appointment of Dr. Jeffrey Brown as Chief Scientific Officer

Nov 1, 2021 | Press Releases

Cambridge, MA, November 1, 2021 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced that Jeffrey Brown, PhD, is joining the company as Chief Scientific Officer (CSO). Dr....

Colombia’s Clínica Imbanaco Joins the TriNetX Network to Increase International Research Collaboration

Oct 8, 2021 | Press Releases

Cambridge, MA, October 8, 2021 — Clínica Imbanaco, a leading research organization in Colombia, has joined the TriNetX network to maximize its research capacity and to expand its collaboration with other research sites around the world. Headquartered in Cali,...

Leading Cancer Center in France, L’Institut de Cancérologie de l’Ouest (ICO), Joins the TriNetX Network to Strengthen Research Capabilities

Sep 27, 2021 | Press Releases

St Herblain, France, September 27, 2021 — L’Institut de Cancérologie de l’Ouest (ICO), one of the leading provincial cancer centers in France, has joined the TriNetX global health research network to facilitate innovative patient care, promote clinical...

Unlocking the Value of Genotypic and Phenotypic Data for Translational Research

Aug 24, 2021 | Blog

The advent of precision medicine is revolutionizing diagnostics and treatment across a broad range of illnesses. Genetic biomarkers are increasingly using DNA, RNA and protein sequencing results, and are an integral part of the precision medicine revolution and...

Why Using Real-World Data Internally During Clinical Trial Design is a Must for Every Sponsor

Aug 4, 2021 | Blog

A family member of mine had exhausted all his available options in his battle with cancer. There was one experimental drug that we believed would help him one last time, but his lab values were not high (sick) enough to meet the eligibility criteria for the trial. So,...

Marshfield Clinic Research Institute Joins TriNetX to Increase Participation in High-Impact Clinical Trial Opportunities

Jul 26, 2021 | Press Releases

Cambridge, MA, July 26, 2021 — The Marshfield Clinic Research Institute, a division of Marshfield Clinic Inc. and the largest private medical research institute in Wisconsin, has joined the TriNetX network to increase clinical trial opportunities for its largely rural...

North Estonia Medical Centre Joins the TriNetX Network to Improve Collaboration with the International Research Community

Jun 29, 2021 | Press Releases

Cambridge, MA, June 29, 2021 — The North Estonia Medical Centre, the leading teaching and research hospital in Estonia, has joined the TriNetX network to expand its collaboration efforts within the international community of research investigators and gain more...

Lessons From ISPOR 2021: The Importance of Real-World Data and Real-World Evidence in Chronic Disease Research and the Impact of the COVID-19 Pandemic

Jun 25, 2021 | Blog, Events

This is the second in a series of posts on the lessons learned from key presentations at the recent ISPOR 2021, specifically as they relate to real-world data (RWD) and real-world evidence (RWE). Our first post focused on the increasing acceptance of RWD and RWE in...

Lessons From ISPOR 2021: The Increasing Acceptance of Real-World Data and Real-World Evidence in Regulatory Decision Making

Jun 14, 2021 | Blog, Events

This is the first in a series of three posts on the lessons learned from key presentations at the recent ISPOR 2021, specifically as they relate to real-world data and real-world evidence. In December of 2018, the FDA released its Framework for the Real-World Evidence...

TriNetX and Takeda Enter Into Agreement to Drive Access to Real-World Data and Analytics

Apr 26, 2021 | Press Releases

Cambridge, MA, April 26, 2021 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), announced today it has entered into an agreement with Takeda Pharmaceutical...